Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ching-Shang Li"'
Publikováno v:
Journal of Lipid Research, Vol 58, Iss 10, Pp 2008-2016 (2017)
An elevated level of lipoprotein (a) [Lp(a)] is a risk factor for CVD. Alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9, is reported to reduce Lp(a) levels. The relationship of Lp(a) reduction with apo(a) size polymo
Externí odkaz:
https://doaj.org/article/754d99a071644969a2dcfe67624f3f09
Publikováno v:
Journal of Lipid Research, Vol 58, Iss 10, Pp 2008-2016 (2017)
An elevated level of lipoprotein (a) [Lp(a)] is a risk factor for CVD. Alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9, is reported to reduce Lp(a) levels. The relationship of Lp(a) reduction with apo(a) size polymo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ab786ae8c27c9868ef9a32e4b3d3af4
https://europepmc.org/articles/PMC5625124/
https://europepmc.org/articles/PMC5625124/
Autor:
Paul A. Perry, Matthew Lam, Ching-Shang Li, Kwame Atsina, Jeffrey Southard, Jesse John Goitia, Garrett B. Wong, Pooja Prasad, Thomas W. Smith, Jeong Won Choi, Walter Douglas Boyd, Benjamin Stripe
Publikováno v:
JACC: Cardiovascular Interventions. 11:S55-S56
Left atrial volume (LAV) has been shown to be a powerful predictor of outcome in various cardiac disease states. There has been no evaluation of the value of LAV for predicting mortality in transcatheter aortic valve replacement (TAVR). This was a si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::178ad65fee98f53edbc1569ff2032439
https://doi.org/10.1016/j.jcin.2018.01.182
https://doi.org/10.1016/j.jcin.2018.01.182